paf

PAF (C16) 是有效的 MAPK 和 MEK ERK 激活剂，可诱导血管通透性增加。PAF (C16) (PAF (C16)) 是血小板活化因子，是一种磷脂衍生介质，也是 PAF G 蛋白偶联受体 (PAFR) 的配体。PAF (C16) 在体外实验中显示出抗凋亡和抗炎活性，通过与其受体 （PAF-R） 相互作用以执行细胞信号传导来抑制 caspase 依赖性凋亡。

Setipafant is an antagonist of the platelet-activating factor.

CMI-392 is a dual 5-lipoxygenase inhibitor and platelet-activating factor (PAF) receptor antagonist (IC50s: 100 and 10 nM).

Ro 24-4736 is an effective and selective platelet-activating factor antagonist.

Homoeriodictyol 7-O-β-D-glucoside (Homoeriodictyol 7-O-glucoside) 是 Viscum coloratum(Kom.)Nakai 的天然产物。Homoeriodictyol 7-O-β-D-glucoside 是血小板活化因子 (PAF) 的拮抗剂。

PAF C-18（十八烷 PAF）是一种天然存在的磷脂类分子，属于血小板活化因子（PAF）家族,作为细胞间信号传导分子，涉及血小板聚集、血管扩张和炎症反应。PAF C-18通过与其特异性G蛋白偶联受体（PAFR）结合参与止血和血栓形成过程，是内源性激动剂。

Azelaoyl PAF是一种强效的PPARγ激动剂，能够竞争性地结合噻唑烷二酮类药物，与罗格列酮（rosiglitazone）的效力相当。​在动脉粥样硬化研究中，Azelaoyl PAF通过上调CD36的表达，促进巨噬细胞对氧化低密度脂蛋白（oxLDL）的摄取。在Friedreich's ataxia（FRDA）患者的成纤维细胞中，Azelaoyl PAF显著提高了铁蛋白的mRNA和蛋白质水平。

Methylcarbamyl PAF C-16(Carbamyl-PAF) 是一种血小板活化因子类似物，具有 PAF 激动特性，可激活激活妊娠组织的炎症，促进早产。

PAF C-18:1 is a naturally occurring phospholipid produced by cells upon stimulation and plays a role in the establishment and maintenance of the inflammatory response. It is less potent than PAF C-16 and PAF C-18 in the induction of neutrophil chemotaxis, but is equipotent to PAF C-16 and PAF C-18 in promoting eosinophil migration. PAF C-18:1 activates the PAF receptor and has been used in antibody binding experiments to determine the importance of an acyl linkage at the sn-2 position for recognition at this receptor.

PAF C-16 is a naturally occurring phospholipid produced upon stimulation through two distinct pathways known as the remodeling and 'de novo' pathways. It is a potent mediator of neutrophil migration and the production of reactive oxygen species and IL-6. Pathological processes involving PAF include necrotizing enterocolitis

2-O-methyl PAF C-16 is a synthetic analog of platelet-activating factor (PAF) featuring a methyl group attached via an ether linkage at the sn-2 position. While the specific biological activities of 2-O-methyl PAF C-16 remain undercharacterized, studies with its C-18 counterpart have demonstrated its ability to modulate various biological processes. These processes include reducing plasma membrane fluidity and hindering the invasiveness of tumor cells in embryonic chick hearts. Furthermore, in rat astrocytes, the C-18 analog prompts the release of significant amounts of nitric oxide (NO) through a mechanism that involves the activation of nitric oxide synthase (NOS).

2-O-Ethyl PAF C-16 作为 PAF 的一种同系物，充当 PAF 受体（Platelet-activating Factor Receptor (PAFR)）的竞争型配体。它能够阻断 PAF 拮抗剂 WEB 2086 与 PAF 受体的结合，表现出 21 nM 的 IC50 值。

Oxidized low-density lipoprotein (oxLDL) encompasses low molecular weight entities that facilitate monocyte differentiation and activate polymorphonuclear leukocytes. A substance, recently isolated and purified from oxLDL and identified as azelaoyl PC, exemplifies this. Similarly, Butanoyl PAF, a compound closely related to azelaoyl PC, maintains over 10% of the agonist potency of platelet-activating factor (PAF). Notably, Butanoyl PAF's concentration in oxLDL surpasses that of enzymatically generated PAF by more than 100-fold, making it a significant signalling molecule within oxLDL.

C18:1 Lyso PAF 一种在生化反应中使用的试剂。

Rupatadine Fumarate (Rinialer) 是一种可口服的长效PAF H1受体的双抑制剂，Ki 值分别为 0.55 μM 和 0.1 μM。它可研究过敏性鼻炎和荨麻疹。

E-6123 is an antagonist of platelet-activating factor (PAF) receptor.

PAF-AN-1是一种新型有效的血小板激活因子受体 (PAF) 拮抗剂，参与研究过敏性死亡。

Foropafant (SR27417) 是一种高效和特异性的血小板活化因子 (PAF) 受体拮抗剂 (Ki: 57 pM)。 Foropafant 有效抑制 PAF 诱导的兔和人血小板聚集。

2-Thio-PAF is a synthetic analog of PAF used in a colorimetric assay for PAF acetylhydrolase.

Lyso-PAF C-16 is a biologically inactive precursor of platelet activating factor.

Dihomo-γ-Linolenoyl PAF C-16 是一种含有 dihomo-γ-linolenoate 的 PAF 类似物，它取代了 PAF C-16 中的乙酸酯部分。

PAF26为针对植物病原真菌Penicillium digitatum、Penicillium italicum及Botrytis cinerea具有活性的抗菌肽。

48740 RP (RP 55779) 是血小板活化因子的拮抗剂。

DF-1111301 是一种具有抗组胺 H1和抗PAF活性的新型抗过敏化合物。